Amylyx Pharmaceuticals
- Market cap
- 3.44B
- P/E (TTM)i
- -19.45
- P/Bi
- 14.39
- EPSi
- -1.53
- Div yieldi
- 0.00%
- 52W posi
- 55%
Anonymous reader poll. Unscientific, not investment advice.
Amylyx Pharmaceuticals ended the session at 27.43, down 2.18%. The company carries a market value of roughly 3.44B, the #2392 most valuable US-listed company we track. Valuation-wise, the P/E sits at -19.89, 180% below the five-year average of 24.93. Wall Street's 9-analyst consensus lands on Buy, with a price target averaging 45.75 (+67% from here). Over the past year the stock has ranged from 10.83 to 41.14; it now sits 55% up that band.
✦ StockVane Quant Insights how this is computed
- Twelve-month momentum in the top 5% of the universe, above its 200-day average.
- Signal has read BUY for 4 months.
- Its last 4 Buy calls have averaged +86% over the following quarter.
- Recent price momentum is +77.1% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has fallen to 12.1% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 28.04
- Open
- 27.72
- Day range
- 27.21 - 28.46
- Avg price
- 27.69
- Volume
- 2.06M
- Turnover
- 56.94M
- Turnover ratei
- 1.88%
- Volume ratioi
- 1.77
- Amplitudei
- 4.46%
- 52-week rangei
- 10.83 - 41.14
Valuation
- P/Ei
- -17.93
- P/E (TTM)i
- -19.45
- P/Bi
- 14.39
- EPSi
- -1.53
- Book value / shi
- 1.91
- Net profit
- -192.03M
- Net assets
- 239.23M
Share structure
- Market cap
- 3.44B
- Float capi
- 3.00B
- Shares out
- 125.51M
- Float sharesi
- 109.55M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 2022-01-07
33.3% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-15.63M net over the window
Short interest
- Shares short
- 13.51M
- % of floati
- 12.13%
- Days to coveri
- 8.64
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Amylyx Pharmaceuticals (AMLX)?
Amylyx Pharmaceuticals last traded at 27.43. The quote on this page refreshes every few seconds while US markets are open.
What is Amylyx Pharmaceuticals's market cap?
About 3.44B.
What is the P/E ratio of Amylyx Pharmaceuticals?
The trailing twelve-month P/E is -19.45, below its own 5-year average of 24.93 — toward the bottom of its historical range (3.87% percentile). See the Valuation tab for the full history.
Does Amylyx Pharmaceuticals pay a dividend?
Amylyx Pharmaceuticals does not currently pay a regular dividend.
Is Amylyx Pharmaceuticals a buy according to analysts?
The consensus of 9 analysts is a Buy rating, with an average 12-month price target of 45.75, which implies 66.8% upside from the current price. This is not investment advice.
What is Amylyx Pharmaceuticals's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Amylyx Pharmaceuticals a B (Buy). Twelve-month momentum in the top 5% of the universe, above its 200-day average. Not investment advice.
Quote time 2026-10-08 07:11:36 · For reference only, not investment advice and not tailored to your situation.